Plant Powered Babies Ltd Secures £98k in Latest Funding Round

Published

Plant Powered Babies Ltd, the Fleet-based innovator behind "Grow with Iris," a plant-based, fortified, and allergen-free growing-up drink for toddlers, has successfully closed a new funding round, securing £98k. This latest capital injection values the company at an estimated post-money valuation of £481.6k.

Incorporated on August 17, 2018, Plant Powered Babies Ltd addresses a critical market need by providing nutritional support for young children aged 12 months to 4 years who have food allergies, intolerances, or follow plant-based diets. Their flagship product, "Grow with Iris," offers a carefully formulated alternative to traditional dairy-based options, ensuring toddlers receive essential nutrients without common allergens. The company currently operates with a lean team of two employees, as per its latest accounts.

The recent £98k funding round, with an allotment date of April 14, 2026, and a filing date of April 23, 2026, marks another step in the company's funding journey. This round follows several previous capital raises. In February 2025, Plant Powered Babies Ltd secured £107k at a valuation of £937.2k. Prior to that, in March 2024, the company raised £155k at an estimated valuation of £1.6m. An earlier round in December 2023 saw the company raise £45k at a valuation of £1.5m. The current round's valuation of £481.6k represents a notable adjustment compared to these earlier funding stages.

The UK's food technology and plant-based sectors continue to attract investment, reflecting growing consumer demand for specialized dietary products. While the overall landscape remains dynamic, companies like Plant Powered Babies Ltd, focusing on niche yet significant market segments, demonstrate the ongoing pursuit of innovation in infant and toddler nutrition. This latest funding will likely support the company's operational activities and market reach for "Grow with Iris" within the competitive plant-based food sector.

Share this

Contact the editorial team at [email protected]